Literature DB >> 3878485

Necrotizing scleritis. A clinico-pathologic study of 41 cases.

N A Rao, G E Marak, A A Hidayat.   

Abstract

Scleritis is not a single clinical or pathologic entity. It has several distinct forms. A clinico-pathologic study of 41 cases of necrotizing scleritis suggests that these different histopathologic forms of disease may reflect different mechanisms of immunopathogenesis. These cases were divided into three main groups: (1) scleral inflammations associated with various systemic autoimmune diseases, including 11 cases of rheumatoid arthritis, three cases of Wegener's granulomatosis, one case of polychondritis, and one case of Goodpasture's syndrome; (2) infectious scleritis, consisting of four cases of herpes zoster ophthalmicus and two cases of pseudomonas scleritis; and (3) idiopathic scleritis, without evidence of systematic disorder, consisting of 19 cases. The first group exhibited predominantly necrosis of the sclera surrounded by granulomatous inflammation and vasculitis. None of these cases showed lymphoid follicles, or healing attempts manifested by proliferation of fibroblasts and blood vessels at the site of inflammation. The idiopathic group revealed few small foci of scleral necrosis and mainly non-granulomatous inflammation. In addition, there was evidence of proliferation of granulation tissue and lymphoid follicles in this group of eyes.

Entities:  

Mesh:

Year:  1985        PMID: 3878485

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

1.  An assessment of ocular elasticity using real time ultrasound and ocular response analyzer in active or remission rheumatoid arthritis.

Authors:  Mehmet Erol Can; Özlem Unal; Meltem Ece Kars; Sukran Erten; Gamze Dereli Can; Necati Duru; Nurullah Cagil
Journal:  Int Ophthalmol       Date:  2018-12-03       Impact factor: 2.031

2.  Corneal autoimmunity in a patient with relapsing polychondritis.

Authors:  F W Albers; M H Majoor; R Van der Gaag
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

3.  Scleritis and multiple systemic autoimmune manifestations in chronic natural killer cell lymphocytosis associated with elevated TCRalpha/beta+CD3+CD4-CD8- double-negative T cells.

Authors:  S Yeh; Z Li; H N Sen; W-K Lim; F Gill; K Perkins; V K Rao; R B Nussenblatt
Journal:  Br J Ophthalmol       Date:  2010-06       Impact factor: 4.638

4.  Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.

Authors:  N Di Girolamo; A Lloyd; P McCluskey; M Filipic; D Wakefield
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

5.  Complications of misdiagnosed and inadequately treated necrotizing scleritis studied by ultrasound biomicroscopy and computerized corneal topography.

Authors:  D Meller; T Böker
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

Review 6.  The role of histopathology in the diagnosis and management of uveitis.

Authors:  M A Côté; N A Rao
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

7.  Haemophilus influenzae associated scleritis.

Authors:  S O Sykes; C Riemann; C I Santos; D M Meisler; C Y Lowder; J P Whitcher; E T Cunningham
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

8.  Anterior segment spectral domain optical coherence tomography imaging of patients with anterior scleritis.

Authors:  Ashleigh L Levison; Careen Y Lowder; Kimberly M Baynes; Peter K Kaiser; Sunil K Srivastava
Journal:  Int Ophthalmol       Date:  2015-11-23       Impact factor: 2.031

9.  Cells perpetuating the inflammatory response in scleritis.

Authors:  W Bernauer; P G Watson; B Daicker; S Lightman
Journal:  Br J Ophthalmol       Date:  1994-05       Impact factor: 4.638

10.  Nodular syphilitic scleritis masquerading as an ocular tumor.

Authors:  Sufiyan I Shaikh; Jyotirmay Biswas; Pukhraj Rishi
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.